Login / Signup

Real-World Primary Care Data Comparing ALT and FIB-4 in Predicting Future Severe Liver Disease Outcomes.

Andrew D SchreinerJingwen ZhangWilliam P MoranDavid G KochSherry LivingstonChloe BaysJustin MarsdenPatrick D MauldinMulugeta Gebregziabher
Published in: Journal of general internal medicine (2023)
High-risk FIB-4 scores demonstrated superior performance compared to abnormal ALT in predicting future SLD outcomes.
Keyphrases
  • primary care
  • current status
  • liver fibrosis
  • metabolic syndrome
  • machine learning
  • general practice
  • glycemic control
  • data analysis